L
LequteMan
Guest
Stocks of several pharmaceutical companies with potential Ebola treatments jumped in extended trade on Tuesday after the U.S. Centers for Disease Control and Prevention confirmed the first case of the virus diagnosed at an hospital in Dallas.
U.S.-listed shares of Tekmira Pharmaceuticals (TKMR.O) jumped 20.6 percent to $25.50, BioCryst Pharmaceuticals (BCRX.O) surged 14.5 percent to $11.20 while Sarepta Therapeutics (SRPT.O) climbed 8.2 percent to $22.83 Reuters says.
#America #Ebola #US #Tekmira #Reuters
U.S.-listed shares of Tekmira Pharmaceuticals (TKMR.O) jumped 20.6 percent to $25.50, BioCryst Pharmaceuticals (BCRX.O) surged 14.5 percent to $11.20 while Sarepta Therapeutics (SRPT.O) climbed 8.2 percent to $22.83 Reuters says.
#America #Ebola #US #Tekmira #Reuters